Solifenacin

Known as: 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Compared with younger people, the elderly are more likely to suffer from overactive bladder (OAB) and to have other… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
  • BJU international
  • 2012
UNLABELLED Study Type--Therapy (prevalence) Level of Evidence 2b. What's known on the subject? and What does the study add… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2011
2011
OBJECTIVES To assess the efficacy and safety of solifenacin add-on therapy to tamsulosin in lower urinary tract symptoms (LUTS… (More)
Is this relevant?
2009
2009
PURPOSE VICTOR was a 12-week, double-blind, placebo controlled trial assessing the safety and tolerability of solifenacin plus… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
OBJECTIVES To assess the cognitive effects of single doses of solifenacin 10 mg compared with placebo (primary objective) and… (More)
Is this relevant?
Review
2009
Review
2009
The succinate salt of solifenacin, a tertiary amine with anticholinergic properties, is used for symptomatic treatment of… (More)
Is this relevant?
Review
2007
Review
2007
Overactive bladder (OAB) is a syndrome characterized by urinary urgency, with or without urgency urinary incontinence, usually… (More)
Is this relevant?
Review
2006
Review
2006
Muscarinic receptor antagonists (antimuscarinics) serve as the cornerstone in the pharmacological management of overactive… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The antimuscarinic profile of the experimental drug solifenacin/YM905 [(+)-(1S,3′R)-quinuclidin-3′-yl 1-phenyl-1,2,3,4… (More)
  • table 1
  • table 2
Is this relevant?